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Abstract
Background: Large mega base-pair genomic regions show robust alterations in DNA methylation levels in multiple
cancers. A vast majority of these regions are hypomethylated in cancers. These regions are generally enriched for
CpG islands, Lamin Associated Domains and Large organized chromatin lysine modification domains, and are
associated with stochastic variability in gene expression. Given the size and consistency of hypomethylated blocks
(HMB) across cancer types, we hypothesized that the immediate causes of methylation instability are likely to be
encoded in the genomic region near HMB boundaries, in terms of specific genomic or epigenomic signatures.
However, a detailed characterization of the HMB boundaries has not been reported.
Method: Here, we focused on ~13 k HMBs, encompassing approximately half of the genome, identified in colon
cancer. We modeled the genomic features of HMB boundaries by Random Forest to identify their salient features,
in terms of transcription factor (TF) binding motifs. Additionally we analyzed various epigenomic marks, and
chromatin structural features of HMB boundaries relative to the non-HMB genomic regions.
Result: We found that the classical promoter epigenomic mark – H3K4me3, is highly enriched at HMB boundaries,
as are CTCF bound sites. HMB boundaries harbor distinct combinations of TF motifs. Our Random Forest model
based on TF motifs can accurately distinguish boundaries not only from regions inside and outside HMBs, but
surprisingly, from active promoters as well. Interestingly, the distinguishing TFs and their interacting proteins are
involved in chromatin modification. Finally, HMB boundaries significantly coincide with the boundaries of
Topologically Associating Domains of the chromatin.
Conclusion: Our analyses suggest that the overall architecture of HMBs is guided by pre-existing chromatin
architecture, and are associated with aberrant activity of promoter-like sequences at the boundary.
Keywords: DNA methylation, Cancer, Machine learning
Background
Cells in an individual adopt hundreds of distinct pheno-
types in their structure and function. This dramatic
phenotypic variability through development and disease
cannot be explained by genetic differences alone. Pheno-
typic variability is also partly encoded by the so-called epi-
genetic variation – varying degrees of chemical
modifications of the DNA and nucleosome histones that
the genomic DNA is wrapped around [1, 2]. Epigenetic
mechanisms are integral to gene regulation; and, their role
in cellular differentiation [3], aging [4] and disease [5] are
areas under active investigation. DNA methylation is one
of the earliest known epigenetic modifications, for which
cellular inheritance mechanisms are now well understood
[6]. Although a direct relationship between locus-specific
DNA methylation and gene expression is well known, a
more specific involvement of DNA methylation in various
diseases, particularly in cancer, is only beginning to be in-
vestigated in a comprehensive manner [5, 7, 8]. Collect-
ively, these studies have identified specific oncogenes that
are hypomethylated, and thus activated, in cancer [9]; cer-
tain tumor suppressor genes that are hypermethylated,
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and thus inactivated [10], and additional methylation
changes in cancer [7, 8].
A recent study showed well-demarcated, large regions,
collectively covering half of the genome, to be differen-
tially methylated in cancer [5]. Moreover, presence of
such large cancer-specific differentially methylated re-
gions (cDMRs) was found to be a general epigenomic
signature across many cancer types [5]. The cDMRs
contain important genes involved in mitotic cell cycle
and matrix remodeling and were shown to exhibit ex-
treme gene expression variability. Moreover, cDMRs are
highly enriched among regions that are differentially
methylated during stem cell reprogramming of induced
pluripotent stem cells [11]. Subsequent investigations re-
vealed that cDMRs significantly overlapped with Lamina
Attachment Domains (LAD), Large organized chromatin
lysine modifications (LOCK) [12] and Partially Methyl-
ated Domains (PMD) in cancer [3]. Additionally, 1 kb
regions flanking cDMR boundaries were shown to be
enriched for DNase hypersensitive sites [13]. Nucleo-
somes were found to be locally enriched in hypomethy-
lated regions in normal tissue [14]. Collectively, these
observations led the authors to postulate a model of can-
cer progression involving epigenetic instability of well-
defined genomic domains [5]. However, investigations of
additional genomic and epigenomic correlations of
cDMRs, and ultimately the causes of cDMR formation
are necessary to gain a better mechanistic understanding
of the role of DNA methylation in cancer, and also to
harness the full potential of these earlier studies for
epigenetic-based cancer diagnostics [15].
Vast majority of large cDMRs are in fact hypomethylated
in cancer, i.e., less methylated in cancer tissue than the cor-
responding normal tissue, and such hypomethylation
happens in large contiguous genomic regions called hypo-
methylated blocks. Here, we focused on previously identi-
fied ~13 k hypomethylated blocks (HMB) in colon cancer,
which encompass approximately half the genome [5]. Given
the length of HMBs and their general overlap with chroma-
tin structural features such as LADs and enrichment of
DNAse hypersensitive sites at HMB boundaries, it is likely
that the genome and the epigenome at HMB boundaries
hold the clues to the underlying mechanisms of genome
wide hypomethylation with distinct boundaries. We there-
fore analyzed a number of genomic and epigenomic fea-
tures at the HMB boundaries including TF binding motifs,
epigenomic marks, and three-dimensional chromatin struc-
tural features (Fig. 1).
Our analysis revealed that the classical promoter epi-
genomic mark – H3K4me3, is highly enriched at HMB
boundary in normal colon tissue, and the boundaries
that are enriched for promoter marks are also enriched
for in vivo binding of the insulator protein CTCF in
colon cancer. We also found that the HMB boundaries
harbor distinct combinations of TF motifs. Our Random
Forest machine learning model that uses TF motifs as
features can distinguish boundaries not only from re-
gions inside and outside HMBs, but surprisingly, from
active promoters as well, with very high accuracy (F-
measure ~ 0.98). Interestingly, the TFs that preferentially
bind at HMB boundaries and their interacting partners
are involved in chromatin modification. Finally, we
found that HMB boundaries are associated with the
boundaries of Topological Associating Domains (TADs),
which form the backbone of chromatin structure [16].
Taken together, our analyses suggest that the overall
architecture of HMBs is guided and restricted by pre-
existing chromatin architecture, while their creation in
Fig. 1 Analysis pipeline. Starting with ~13,000 HMBs, we perform a number of tests to assess the association of HMBs and HMB boundaries with
Topological Associating Domains, Physical interaction within and across HMBs, profiles of various epigenetic marks, and CTCF binding. In addition,
we identified TF motifs enriched at the HMB boundaries relative to various controls and assessed the ability of a random forest model to distinguish
HMB boundaries from other domains based on TF binding site motifs. Finally, we assessed the spatial profile and functions of enriched TF motifs and
their interacting partners
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cancer may be caused by aberrant activity of promoter-




We obtained coordinates for 13,540 reported long hypo-
methylated block (HMB) in colon cancer with an aver-
age and median size of 144 kbps and 39.5 kbps,
respectively [5]. We define the boundary of an HMB as
its 5 kb flanking regions outside the HMB plus an add-
itional 1 kb inside the HMB. The choice of 5 kb for the
flanking region is arbitrary and 1 kb inside is included to
offset a lack of precision in localizing HMB boundary
(e.g., Supplementary Figure 10b of [5]).
Random Forest based discrimination of HMB boundaries
We used Random Forest classifiers [17] to distinguish
the resulting 27,080 6-kb-long HMB boundary from
other genomic regions: (1) inside HMB - randomly se-
lected 6 kb block from inside of the HMBs, excluding
HMB boundaries; (2) outside HMB - randomly selected
6 kb regions from outside of the HMBs excluding HMB
boundaries; (3) promoter - randomly selected 6 kb pro-
moters for protein-coding genes, including 5 kb up-
stream and 1 kb downstream of the transcription start
site using the Ensembl annotation (www.ensembl.org,
version 69). Given two sets of sequences (e.g., HMB and
inside-HMB), and a set of characteristics (i.e., features)
describing each sequence (e.g., putative binding sites for
a set of transcription factors), the Random Forest classi-
fier learns the combinations of features that distinguish
one set of sequences from the other. When given an un-
foreseen sequence and its features, our Random Forest
classifier can determine the set to which the sequence
belongs to based on its features. The more distinguish-
ing the features of the two sequence sets are (e.g., HMB
and inside-HMB), the higher the accuracy with which
our classifier can determine the set to which a new se-
quence belongs. To design the right control while build-
ing the Random Forest classifier, in each sequence set
we selected the same numbers of regions for each pair-
wise classification task, while controlling for the GC
content. For instance, when classifying between HMB
boundaries and promoters, we selected two sets of re-
gions that are non-overlapping and with similar GC con-
tent distribution. Finally, each set of sequences were
composed of ~20 k sequences.
As feature sets in the Random Forest classifiers, 931
motifs corresponding to vertebrate TFs were obtained
from TRANSFAC v2011 [18]. Putative motif binding
was determined in each 6 kb region using the FIMO
(Find individual Motif Occurrences) software [19]. Each
6 kb region was represented as a 931-dimensional
feature vector where the measurement of each dimen-
sion is the count (0 or greater) of binding sites of each
corresponding motif within the 6 kb region. To build
each classifier, we used the implementation from ‘ran-
domForest’ package [20]; we used the default parameter
setting except for the number of features (m) to be sam-
pled randomly at each split of a decision tree. The de-
fault value of m is typically one-third of total number of
features. However, we choose m = 92 after tuning the
random forests for optimal parameters. While tuning,
the classifier was built with default m, and the out-of-
bag error was estimated to update the value of m. In a
random forests classifier, each tree was grown to the lar-
gest extent possible, i.e., without any pruning and to
decide the classification of an unseen sequence the ma-
jority vote of the trees was considered.
We assessed the classification accuracy using a 70–
30 % split of the data into training and test sets, chosen
randomly, for each of the pairwise classification tasks
distinguishing HMB boundaries from the three sets of
regions: inside HMB, outside HMB, and promoters. The
classification accuracies are reported using both area
under curve (AUC) of the receiver operating curve and
harmonic mean of precision and recall (F-measure). As
an additional robustness measure, we also performed the
HMB boundary versus promoter classification task using
Support Vector Machine (SVM) implemented in R stat-
istical package (https://cran.r-project.org/web/packages/
e1071/), based on 10-fold cross-validation.
CpG island overlap as an additional feature in the
Random Forest Classifiers
CpG islands tend to exhibit increased methylation in
colon cancer. Consequently, HMBs are frequently
‘broken’ by CpG islands [5], and thus their boundaries
frequently overlap CpG islands. Therefore, motifs can be
found more frequently in HMB boundaries than inside
or outside HMBs simply due to the presence of CpG
islands. We used the fraction of the 6 kb region that
overlaps any of the 28,681 CpG islands annotated in the
UCSC genome browser (genome.ucsc.edu) as an add-
itional feature in the classification task, in addition to
controlling for GC content in the classification task.
Identifying most discriminating motifs
We determined the importance of each motif in distin-
guishing between region types using Mean Decrease Ac-
curacy obtained from the Random Forest classifier.
Mean decrease accuracy of a feature measures the re-
duction in classification error upon including the corre-
sponding feature in the model, and thus represents the
importance of the motif in distinguishing HMB bound-
aries from a specific control region set; the higher the
mean decrease accuracy the more important the feature
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is. We also determined enrichment of each motif in
HMB boundaries relative to each control set (inside, out-
side, or promoters) using Fisher’s exact test. The motif is
considered as enriched (depleted) in the HMB boundar-
ies relative to the control when the corresponding odds
ratio is greater than 2 (less than 0.5).
Epigenetic data processing
Genome-wide profiles of six histone marks (H3K4me1,
H3K4me3, and H3K9ac, H3K9me3, H3K27me3 and
H3K36me3) in normal colon mucosa tissue were down-
loaded from the Roadmap Epigenetics Project website
(www.roadmapepigenomics.org/). We calculated average
signal for each histone mark (at 20 bp resolution as pro-
vided by the Roadmap project) within each 6 kb region
in HMB, inside HMB, outside HMB, and promoter re-
gion. ChIP-Input was also obtained for normalization.
To get the normalized values, we took the log ratio of
methylation levels of histone marks and their corre-
sponding ChIP-Input at the base-pair resolution.
Chromatin interaction measurement in hypomethylated
blocks
To obtain the chromatin interaction information, we
used Hi-C experimental data, which provides the
spatial proximity information between pairs of differ-
ent genome segments [21]. We obtained Hi-C data
for human embryonic stem cell (hESC) and lung fi-
broblasts (hIMR90) cell lines from [16] as normalized
interaction matrices with 40 kb bin size denoting the
frequencies of physical contacts among pairs of gen-
omic loci at a genome-wide scale. We mapped those
40 kb bins onto the HMBs and disregarded partially
mapped blocks so HMBs smaller than 40 kb were ex-
cluded from the analysis. We then measured inter-
action strength within each HMB as the sum of all
pairwise bin interactions within the HMB divided by
the number of 40 kb bins within the HMB. As a
negative control, the same was done for randomly
chosen non-overlapping genomic regions with same
lengths as HMBs.
Measuring proximity to topologically associating domains
We downloaded the locations of 3,029 topological as-
sociating domains (TADs) from [16] for hESC cell
lines. For each boundary of the TAD we obtain the
minimum distance to a HMB boundary. As a control,
we selected 13 k random non-overlapping blocks of
same sizes as HMBs. As for real HMBs, we also ob-
tained the minimum distance of each TAD boundary
to a random block selected for control.
Fisher’s exact test: calculating enrichment/depletion of
motif in different regions and finding motif interaction
with chromatin modification enzymes (CME)
The contingency table for testing enrichment/depletion
of each motif is shown below.
a (respectively b) denotes the number of positive ex-
amples in which a motif is present (respectively absent).
Similarly, c (respectively d) denotes the number of nega-
tive examples in which a motif is present (respectively
absent).
The contingency table for testing interaction with
CME is shown below.
a (respectively b) denotes the number of selected mo-
tifs that themselves are CMEs or do not interact with a
CME (respectively all others). Similarly, c (respectively
d) corresponds to the control for testing CMC inter-




Our objective is to characterize genetic and epigenetic
features that demarcate hypomethylated blocks in can-
cer, in order to gain insights into the mechanism and
functional implications of these genomic blocks. Our
findings are organized as follows: First, we determined
and examined epigenomic marks that are enriched at
HMB boundaries. Second, we analyzed genomic proper-
ties, namely, putative binding sites for all vertebrate
transcription factors at HMB boundaries. Third, we
showed that many of the motifs enriched at HMB
boundaries exhibit specific positional distributions
aligned with the HMB boundary. Fourth, we investigated
specific transcription factor motifs enriched at HMB
boundaries and their links to chromatin modifying en-
zymes (CMEs), in order to understand the mechanistic
link between transcription factor binding and chromatin
structure. Fifth, we furthered examined the link between




Selected motifs Other motifs
Interact with CME a c
Do not interact with a CME b d
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and CMEs by analyzing the association between HMB
boundaries and topologically associating domains (TAD)
boundaries, which define the structural backbone of the
chromatin. Finally, we examined at HMB boundaries,
the putative sites for CTCF, which acts both as mediator
of chromatin loop formation as well as an insulator that
restricts the spread of chromatin marks.
Boundaries of hypomethylated blocks are enriched for
promoter-associated histone mark H3K4me3
Previous studies have shown cross-talk between DNA
methylation and various histone modifications [22]. Given
that HMBs exhibit relatively sharp demarcation of their
boundaries [5], we investigated the patterns of various his-
tone marks in normal colon tissue in the vicinity of HMB
boundaries. We summarized the signal strength of six his-
tone marks in 20 kbp flanking the HMB boundaries (see
Methods) from human colon tissue data downloaded from
the Epigenetic Roadmap Website (www.roadmapepigen-
omics.org). Histone marks H3K4me3 and H3K9ac, known
to be associated with active promoters, showed a distinct
peak immediately outside the HMBs (Fig. 2). Patterns for
other histone marks (H3K4me1, H3K9me3, H3K27me3
and H3K36me3) did not show noticeable trends at HMB
boundaries (Additional file 1: Figure S1a–d).
Given the enrichment for promoter histone marks at
the HMB boundaries, we considered the possibility that
the HMB boundaries coincide with or are near gene pro-
moters. We excluded the HMB boundaries (5 kb outside
the HMB and 1 kb inside the HMB) that overlapped
with the transcription start site of any gene or pseudo-
gene (including non-coding genes), based on Gencode
annotation [23], and repeated the analysis of histone
mark pattern. The remaining boundaries still showed a
significant, but smaller than previously mentioned peak,
at the HMB boundary. For instance, as shown in Fig. 2c,
H3K4me3 signal strength in 3 kb outside HMBs was
lower than that in the regions immediately outside
HMBs. The mean of normalized signals (see Methods)
at the HMB boundaries was −0.82, while at random 3 kb
regions outside of HMBs the mean signal was −1.01
(Wilcoxon test p-value = 7.08e-42). This suggests that
the observed enrichment of histone modification at
HMB boundaries is not entirely due to annotated pro-
moters for genes or pseudogenes.
HMB boundaries harbor distinguishing TF binding motifs
Given the enrichment for promoter-like histone marks
near HMB boundaries, we assessed whether HMB
boundaries are distinct from non-boundary regions as
well as other known promoters in terms of their TF
binding motifs. For this purpose, in addition to the
HMB boundary regions we defined three sets of regions
of 6 kb length (see Methods): (1) Inside: regions within
HMBs, (2) Outside: regions between HMBs, and (3) Pro-
moters. All regions were non-overlapping and in each
pairwise comparison task, the GC content was similar in
the two sets of regions (See Methods). For each 6 kb re-
gion we constructed a 932-dimensional feature set quan-
tifying the fraction of CpG Island overlaps and the
number of motif matches for each of the 931 vertebrate
TF motifs from TRANSFAC, v2011 [18], using FIMO
[19] as the motif search tool. We then applied Random
Forest (RF) classifiers on the feature set to distinguish
HMB boundaries from the other genomic region sets
under study. We trained the RF using 70 % of the data
and noted the classification accuracy on the remaining
30 % of the data. The classification performances are
shown in Table 1. Surprisingly, HMB boundaries can be
distinguished from even other promoters with very high
accuracy (F-measure ~ 0.978); Fig. 3 shows the ROC
curve corresponding to classification between HMB
boundaries and promoters (ROC curves for the rest of
the classification tasks are presented in Additional file 1:
Fig. 2 Histone modifications enriched near HMB boundaries. Mean normalized ChIP signal for (a) H3K4me3 and (b) H3K9ac as a function of genomic
distance to HMB boundary. The dotted vertical line (pink) depicts the precise location where the HMB starts while the shaded (cyan) region is the 3 kb
HMB boundary region as defined in this paper. The solid vertical lines (pink) indicate inside (right) and outside (left) of HMBs. c Distribution of
normalized H3K4me3 signal in HMB boundary regions and outside HMBs
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Figure S2). We were able to recapitulate the RF results
of HMB boundary versus promoter classification accur-
acy using Support Vector Machine (SVM) (F-measure
~0.97) – SVM is a classic tool for learning the combin-
ation of features of set of sequences that distinguishes
the set from the control set. This suggests that the motif
composition at HMB boundaries is distinct from those
in promoter regions. We also obtained high discrimina-
tive performance when distinguishing HMB boundaries
from regions inside HMBs (F-measure ~0.90).
Positional distribution of discriminating motifs
Next we assessed whether TF motifs that distinguish
HMBs exhibit a positional bias relative to the HMB
boundaries. To prioritize the motifs we used the Mean
Decrease Accuracy as the measure of a motif ’s relevance
to a specific discrimination task (see Methods). Additional
file 2: Table S4 lists the top 20 most discriminating motifs
in the classification of HMB boundaries against inside-
HMB, outside-HMB, and promoters. Also, we only se-
lected 46 motifs that were enriched above a threshold in
the boundary (see Methods). For each of the 46 motifs, we
plotted the frequency of the motif in 100 bps windows
within the 6 kb HMB boundary regions, averaged over all
HMB boundaries. Figure 4 shows the positional profile for
the two most discriminating transcription factors ZFX
(TRANSFAC id M01593) and SP1 (TRANSFAC id
M00196) as an illustration; the profiles of all other motifs
are included in Additional file 1: Figure S3. We next esti-
mated for each motif the positional bias of binding sites
within HMB boundaries by taking the most extreme (high
or low) frequency of binding motifs among all 100 bp win-
dows. The extreme frequencies of binding motifs were
normalized and converted to Z-scores across all 100 bp
windows in the 6 kb regions. Z-score provides a standard-
ized measurement of deviation from the mean frequency
of binding motifs across the 46 motifs. We found that the
majority of extreme frequency was located near the HMB
boundaries: within 6 k block the median location is 5574
from the outside of the boundary with a standard
deviation of 892. Z-scores for all motifs ranged from 2.35
to 5.94 with a mean of 3.48 (See Additional file 1: Figure
S3 for all positional profiles, the corresponding Z-score
for both boundary and promoter). This suggests that
Table 1 Performance of Random Forest classifier for HMB boundaries relative to other genomic regions
Sensitivity Specificity F-measure AUC Size of data set
Boundary vs. Inside 0.90 0.89 0.90 0.96 41,425
Boundary vs. Outside 0.84 0.81 0.83 0.91 41,430
Boundary vs. Promoter 0.98 0.97 0.98 0.99 31,051
Boundary vs. Promoter (SVM) 0.97 0.97 0.97 0.99 31,051
‘Inside’ and ‘outside’ refer to regions inside or outside HMBs, respectively. These regions were selected to match the length and CG content of HMB boundaries
(see Methods). The last row contains the results of a Support Vector Machine classifier that was used to replicate the Random Forest result on the HMB boundary
vs. Promoter region classification. In all cases, 70 % of the data was used as training, and 30 % was used for testing. Sensitivity, Specificity and F-measure were
noted as the optimal F-measure
Fig. 3 ROC curves for classifiers distinguishing HMB boundaries and promoters based on TF binding site motifs. a Using Random Forest classifier,
b Using Support Vector Machine classifier. Each ROC curve is based on predictions on a held-aside set of genomic regions (see Methods)
Sharmin et al. BMC Cancer  (2016) 16:88 Page 6 of 10
discriminating motifs have a skewed positional distribu-
tion that exhibits extreme enrichment very close to the
HMB boundaries.
Characterization of the most discriminating transcription
factor motifs
Some TFs are directly involved in histone modification
and some other TFs are known to interact with chroma-
tin modification enzymes [24]. We assessed whether the
TFs whose motifs are most discriminative of HMB
boundaries are involved in chromatin modification, ei-
ther directly or by interacting with a chromatin modifi-
cation enzyme. We first compiled a set of 492 genes
annotated as Chromatin Modification Enzymes (CME)
from the ENSMBL database. For each of the 931
TRANSFAC motifs, we obtained the Ensemble Gene ID
for the corresponding TF protein and then obtained the
set of annotated proteins known to interact with the par-
ticular TF using the string-db R package, which is based
on the STRING database of protein interactions [25].
For each pair of regions compared (say, HMB boundary
versus Promoter), we assessed whether the most dis-
criminating motifs and their interacting partners are
enriched for CMEs. To do so we obtained the top 20,
25, 40, and 50 motifs according to Mean Decrease Ac-
curacy (see Methods), and compared the prevalence of
CMEs among these motifs and their interacting partners
against the rest of the available TF proteins as back-
ground. For each comparison, we assessed enrichment
of CMEs using Fisher’s Exact test. We found that the
most discriminating TF motifs (Additional file 2: Tables
S1–S3) in HMB boundaries and their interacting part-
ners were enriched for CMEs relative to all other regions
(inside HMB, outside HMB, and promoter regions,
Table 2). Encouragingly, the fold enrichment of CMEs
increases monotonically as we restrict ourselves towards
more significant TFs, from top 50 to top 20 motifs only.
These results suggest that relative to inside and outside
regions, the HMB boundaries not only harbor distinct
motifs but these motifs could also be responsible for dis-
tinct epigenetic profiles at HMB boundaries.
Additional file 2: Table S5 lists the 135 CMEs that
interact with the top 20 enriched motifs in each of the
three comparisons – boundary versus inside, outside, and
promoter. Interestingly, these 135 CMEs include two
DNA methyltransferases DNMT3A/B, and also P300,
which is a well-known marker of regulatory enhancers.
Hypo-methylated blocks may be informed by chromatin
structure
Our analysis so far suggests that the HMB boundary re-
gions possess distinguishing genomic and epigenomic
characteristics, which may underlie their role as nucle-
ation or termination of the methylation alteration. In
addition, it is likely that the spread and confinement of
epigenomic alteration within HMBs may be informed by
preexisting chromatin organization and structure. This
is suggested by a previous study that showed a signifi-
cant overlap between cDMRs and LADs [5].
Based on Hi-C assay, which provides quantitative evi-
dence of physical interactions between genomic loci,
previous work has identified the so-called Topological
Associating Domains (TAD), which are mega-base-sized
genomic regions with a much greater interactions within
the regions relative to across regions. TADs are relatively
conserved across cell lines and species, and thus repre-
sent an underlying structural backbone of the chromatin.
Based on 3,127 TADs reported in [16], we measured the
Fig. 4 Positional profile of binding sites for ZFX and SP1. Number of occurrences in 100 bp windows as function of genomic distance to HMB or
promoter start site for TFs ZFX_01 (a) and SP1_Q6 (b). The dotted vertical line indicates the location of HMB and promoter respectively. ‘Outside’
and ‘inside’ correspond to 6 kb sized genomic regions outside or inside HMBs respectively
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proximity of each TAD boundaries to the closest HMB
boundary, and compared the resulting positional distri-
bution with that for a control set of randomly selected
genomic loci. TAD boundaries are significantly closer
(~43 kb) in genomic distances to a HMB boundary com-
pared with the expected ~71 kb (ratio of mean = 3.8, ra-
tio of median = 1.7, Wilcoxon test p-value = 5.4e-55,
Fig. 5a).
Because TADs were identified based on a statistical
overrepresentation of intra-region interaction, we also
directly assessed using the Hi-C data, whether HMBs
show an enriched intra-block interaction compared to
inter-block interactions. Unfortunately Hi-C data is not
available for human colon tissue. Based on the Hi-C data
in hESC, and hIMR90 cell line (yuelab.org/hi-c/down-
load.html), as shown in Fig. 5b-c, we found a signifi-
cantly greater interactions within HMBs compared to
within random blocks controlled for length (For hESC:
mean_HMB = 32, mean_Random = 27, Wilcoxon test
p-value = 3.2e-38. For hIMR90: mean_HMB = 21.8,
mean_Random = 18.3, Wilcoxon test p-value = 4.1e-34).
Overall, these analyses suggest that long domains of al-
tered methylation in colon cancer may in part be in-
formed by the underlying chromatin structure of the
normal cell.
CTCF binding sites coincide with the H3K4me3 signal in
HMB boundaries
Among its numerous roles, CTCF is known to act as in-
sulator by restricting the spread of heterochromatin, and
is also involved in the maintenance of three dimensional
chromatin conformation in part by stabilizing long-
distance interactions [26]. Consistent with the role of in-
sulator, CTCF binding sites are enriched between TADs
[16]. We assessed whether CTCF binding sites are
enriched near HMB boundaries. We downloaded the in
vivo CTCF binding sites for colon cancer tissue from
CTCFBSDB 2.0 database (insulatordb.uthsc.edu/). We
found that HMBs were often bounded by CTCF binding
sites. The frequency of CTCF in the 6 kb HMB boundar-
ies (21 %) was significantly higher than random blocks
inside (14 %) and outside (18 %) HMBs, where the total
number of regions in each set was ~20 k. Moreover and
interestingly, the HMB boundaries with a CTCF binding
site had significantly higher levels of H3K4me3 signal
than the boudaries without a CTCF binding site (ratio of
mean = 1.4, Wilcoxon test p-value = 3.7e-24). Overall,
this suggests that HMB boundaries are enriched for
CTCF, as is expected for structural chromatin domains,
but the presence of CTCF is in fact linked to the
promoter-like characteristic of HMB boundaries.
Table 2 Enrichment of chromatin modification enzymes among the most discriminating TF motifs and their interacting partners
Classification Top 20 Top 25 Top 40 Top 50
OR P-Value OR P-Value OR P-Value OR P-Value
Boundary-Inside 1.66 2.8e-9 1.57 6.1e-8 1.48 7.5e-7 1.46 7.8e-7
Boundary-Outside 1.61 3.0e-8 1.53 3.5e-7 1.50 2.4e-7 1.45 1.4e-6
Boundary-Promoter 1.64 7.6e-9 1.56 1.2e-7 1.44 3.9e-6 1.45 1.1e-6
Odds ratio (OR) and Fisher’s Exact test P-value for a chromatin modification enzyme enrichment test using the most discriminating (Top 20, 25, 40 or 50)
TF binding site motifs for each classification task (as described in Table 1)
Fig. 5 Hypo-methylated blocks associate with topological domains in the chromatin structure. a Boxplot of genomic distance (in bases) between
TAD boundary (obtained from hESC) to nearest colon cancer HMB boundary. Distances between TADs and random 6 kb genomic regions are
included as background. b Boxplots of average Hi-C interaction for bins within HMBs in hESC, with average interactions randomly generated genomic
regions of similar size and GC content included as background. c same as (b) and for IMR90 cell line
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Discussion
In this study, we have characterized the regulatory land-
scape of large regions of methylation loss in colon can-
cer. We have found that the putative binding sites for
specific TFs potentially involved in chromatin modifica-
tion are distinguishing features of the DNA sequence at
HMB boundaries. We also found that while activating
histone marks common to promoters are enriched in
HMB boundaries, HMB boundaries still show a distinct
pattern of TF motif profile relative to known promoters.
Finally, we found that the specific domains where HMBs
occur are reflective of general chromatin organization of
the normal cell.
Based on our qualitative assessment, we found that
TFs enriched in HMB boundaries include those involved
in demethylation, cell proliferation and cell cycle, hall-
marks of cancer. For instance, for the most discrimina-
tive motif Sp1, high expression of Sp1 is known to
disrupt cell cycle. Sp1 deregulation might be beneficial
for tumor cells and its overexpression is known to in-
duce apoptosis of untransformed cells [27]. Other mem-
bers of Sp TF family also play roles in metastasis and
growth of different tumor types [28]. In our analysis,
multiple TFs from this family were found to be enriched
in HMB boundaries. Zfx presents another illustrative ex-
ample, as it controls the self-renewal of embryonic and
adult hematopoietic stem cells [29]. Zfx also controls
BCR-induced proliferation and survival of B lymphocytes
[30]. Another detected TF, FoxO is central to the inte-
gration of growth factor signaling, oxidative stress and
inflammation, and is involved in tumor suppression [31]
and DNA demethylation process in B-cell development
[32]. Finally, TF Zfp281 is known to play a role in cell
pluripotency [33], chromatin remodeling [34], and inhib-
ition of nanog auto-repression [35].
Loss of methylation in large domains has been identified
as a consistent and stable mark in solid tumors [5, 36].
While the degree of methylation loss increases with tumor
progression, intra-sample variability in DNA methylation
and gene expression is greater within these domains [36].
These findings point to a general loss of epigenomic and
transcriptomic stability that is essential to the normal be-
havior of the cell. The co-localization of these domains
with lamin-associated domains [5], with TADs (as found
in this study), and the enrichment of CTCF binding in the
boundaries of these domains suggest that a loss of chro-
matin organization is concomitant with this loss of epige-
nomic and transcriptomic stability.
We note a few limitations of our analyses. Our ana-
lyses are based on 6 kb region flanking the HMB bound-
ary. This choice, while reasoned, is somewhat arbitrary.
Although our analyses suggest that HMB formation is
associated with specific genomic, epigenomic, and chro-
matin features, it does not clarify the causality leading
from TF binding to hypomethylation and ultimately to
the previous observed aberrant gene expression in
HMBs. While we observed specific patterns of certain
epigenomic marks at HMB boundaries, these may be ul-
timately a reflection of the genomic characteristics [37].
Moreover our analysis is based on putative binding site
and not based on in vivo binding data for the TFs, which
are currently not available for a majority of TF. Never-
theless, our analyses do suggest a potential link between
specific genomic marks and HMB boundaries, which re-
quire future experimental studies of the underlying
mechanisms.
Conclusion
Taken together, our analyses suggest that the overall
architecture of HMBs is guided by pre-existing chroma-
tin architecture, while their creation in cancers may be
caused by aberrant activity of promoter-like sequences
at the boundary. Our results are consistent with a model
where a loss of chromatin organization and a concomi-
tant loss of epigenetic stability make previously inaccess-
ible TF binding sites accessible for proteins involved in
chromatin modification as well as cellular fate, whose
binding sites are enriched within domains of inaccessible
chromatin where HMBs reside. The binding of specific
DNA binding factors at HMB boundaries may further




Additional file 1: Figure S1. Pattern of histone marks near HMB
boundaries: (a) H3K4me1, (b) H3K9me3, (c) H3K27me3, (d) H3K36me3.
Figure S2. ROC for HMB boundaries versus inside/outside for the test set.
Figure S3. Frequency plots for the TF motifs listed in Additional file 2:
Table S4. (PDF 1711 kb)
Additional file 2: Table S1. TF motifs from classification of boundary vs.
promoter. Table S2. TF motifs from classification of boundary vs. inside.
Table S3. TF motifs from classification of boundary vs. outside. Table S4.
Union of top 20 motifs from three classifications. Table S5. List of
chromatin modifying enzymes interacting with top 20 available Ensemble
Gene Id. (XLS 243 kb)
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